A clinical study of low temperature treatment on propofol to relieve pain of propofol injection in patients with non convulsive electric shock

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000030401

Enrollment

Unknown

Registered

2020-03-01

Start date

2020-03-01

Completion date

Unknown

Last updated

2020-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Interventions

Group 1:propofol (0-5?)

Group 2:propofol (6-10?)

Group 3:propofol (11-15?)

Group 4:propofol (16-20?)

Group 5:propofol (21-25?)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients with severe neuropsychiatric disorder who received non-convulsive electroconvulsive therapy and informed consent in our hospital; 2. Aged 18 to 60 years; 3. ASA I - ASA II.

Exclusion criteria

Exclusion criteria: 1. Patients with ASA III or above with other severe heart, lung, liver and kidney diseases; 2. Patients with any propofol contraindications.

Design outcomes

Primary

Measure	Time frame
visual analogue scale;Surgical Pleth Index, SPI;TOTAL score;	—

Secondary

Measure	Time frame
Hemodynamic indicators (blood pressure, heart rate);Duration of epilepsy;recovery time;	—

Countries

China

Contacts

Public ContactCai Jun

The Third Affiliated Hospital of Sun Yat-Sen University

beenjoy@qq.com+86 13512728239

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026